Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

A longitudinal study of neurocognitive function in individuals at-risk for psychosis.

Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA.

Schizophr Res. 2006 Dec;88(1-3):26-35.

PMID:
16930949
2.
3.

Neurocognitive functioning in schizophrenia and during the early phases of psychosis: targeting cognitive remediation interventions.

Zaytseva Y, Korsakova N, Agius M, Gurovich I.

Biomed Res Int. 2013;2013:819587. doi: 10.1155/2013/819587. Review.

4.

Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.

De Herdt A, Wampers M, Vancampfort D, De Hert M, Vanhees L, Demunter H, Van Bouwel L, Brunner E, Probst M.

Schizophr Res. 2013 Sep;149(1-3):48-55. doi: 10.1016/j.schres.2013.06.017. Review.

PMID:
23830855
5.

Treatment implications of the schizophrenia prodrome.

Kaur T, Cadenhead KS.

Curr Top Behav Neurosci. 2010;4:97-121. Review.

6.

Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention.

Niendam TA, Jalbrzikowski M, Bearden CE.

Neuropsychol Rev. 2009 Sep;19(3):280-93. doi: 10.1007/s11065-009-9108-z. Review.

7.

Evaluating and treating the prodromal stage of schizophrenia.

Perkins DO.

Curr Psychiatry Rep. 2004 Aug;6(4):289-95. Review.

8.

Multimodal Brain and Behavior Indices of Psychosis Risk.

Gur RC.

Nebr Symp Motiv. 2016;63:205-24. Review. No abstract available.

PMID:
27627828
Items per page

Supplemental Content

Support Center